Alloplex Biotherapeutics, LLC

KALA BIO, Inc. is a clinical-stage biopharmaceutical company based in Arlington, MA, dedicated to addressing rare and serious eye diseases through innovative therapies. Utilizing their proprietary mesenchymal stem cell secretome (MSC-S) platform, the company is developing treatments aimed at preserving vision and enhancing the quality of life for patients with challenging ocular conditions. The company's notable pipeline includes KPI-012, a topical therapy currently in Phase 2b clinical study for persistent corneal epithelial defect, and KPI-014, an intravitreal therapy in preclinical development for inherited retinal diseases. Having secured FDA approval for two ophthalmic products, KALA BIO is now focusing on biologics to further its mission of transforming the treatment landscape for ophthalmic diseases. Generated from the website

Eisai Inc, headquartered in Nutley, NJ, is a global pharmaceutical company dedicated to human health care, focusing on the development of innovative therapies for neurological disorders and various types of cancer. With a commitment to corporate responsibility and community involvement, Eisai emphasizes patient support through programs like the Magnolia Patient Support Programs and the Eisai USA Foundation. The company operates multiple facilities, including the Eisai Center for Genetics Guided Dementia Discovery in Cambridge, MA, and has a robust pipeline of medicines aimed at addressing significant health challenges. Eisai's collaborative approach in research and development underscores its mission to improve patient outcomes and enhance quality of life. Generated from the website

Eusa Pharma, a part of the Recordati Group, specializes in the development and delivery of innovative pharmaceuticals aimed at treating rare diseases and conditions. Operating with a commitment to sustainability and corporate governance, the company emphasizes the importance of education and research within its workforce. The organization is dedicated to ensuring the proper functioning and quality of its digital services, utilizing user navigation data to enhance user experience while adhering to data protection regulations. Eusa Pharma values transparency and user rights, allowing clients to control their personal data in accordance with applicable privacy legislation. Generated from the website